Suffolk Capital Management LLC lifted its stake in UnitedHealth Group Inc (NYSE:UNH) by 14.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,187 shares of the healthcare conglomerate’s stock after acquiring an additional 7,491 shares during the period. Suffolk Capital Management LLC’s holdings in UnitedHealth Group were worth $11,592,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of UNH. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group during the second quarter valued at $110,000. Bruderman Asset Management LLC bought a new stake in UnitedHealth Group during the second quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares during the period. BDO Wealth Advisors LLC bought a new stake in UnitedHealth Group during the second quarter valued at $121,000. Finally, Acrospire Investment Management LLC boosted its stake in UnitedHealth Group by 130.7% during the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after buying an additional 400 shares during the period. 86.01% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts recently issued reports on UNH shares. Cantor Fitzgerald lifted their price objective on UnitedHealth Group to $225.00 and gave the company an “overweight” rating in a research note on Wednesday, October 18th. Wells Fargo & Co reissued an “outperform” rating and set a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Credit Suisse Group started coverage on UnitedHealth Group in a research note on Thursday, November 2nd. They set an “outperform” rating and a $233.00 price objective for the company. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Finally, Royal Bank of Canada lifted their price objective on UnitedHealth Group to $244.00 and gave the company an “outperform” rating in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $226.74.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the previous year, the company posted $2.17 earnings per share. The company’s revenue was up 8.7% compared to the same quarter last year. sell-side analysts forecast that UnitedHealth Group Inc will post 9.99 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a $0.75 dividend. The ex-dividend date was Thursday, November 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.33%. UnitedHealth Group’s dividend payout ratio is currently 34.09%.
In other news, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. In the last quarter, insiders sold 34,630 shares of company stock worth $7,669,416. Company insiders own 0.89% of the company’s stock.
WARNING: “Suffolk Capital Management LLC Has $11.59 Million Stake in UnitedHealth Group Inc (UNH)” was originally published by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.com-unik.info/2018/01/09/suffolk-capital-management-llc-has-11-59-million-stake-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.